Medications & Supplements/Topical Products

Carie Boyd Pharmaceuticals LET Topical Gel Recalled for Product Mix-up

Agency Publication Date: December 6, 2023

Summary

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop has recalled 190 syringes of LET Gel (lidocaine, epinephrine, and tetracaine). The recall was issued because of a product mix-up resulting in an incorrect formulation of the topical gel. If you have been prescribed this medication, please consult with your healthcare provider or pharmacist.

Risk

Using a topical anesthetic with an incorrect formulation may result in inadequate numbing during medical procedures or unintended side effects from incorrect ingredient levels. No injuries or incidents have been reported to date.

What You Should Do

This recall involves 3mL single-use syringes of LET Gel (Lidocaine HCL 4%, Epinephrine Bitartrate 0.18%, and Tetracaine HCL 0.5%) sold under the Carie Boyd Pharmaceuticals brand. Affected units are marked with NDC 73271-1003-1 and lot number 09202023@7 (or 09202023) with an expiration date of 03/18/2024.
If you have health concerns after using this product, contact your healthcare provider or pharmacist.
Return any unused product to the place of purchase for a refund, throw it away, or contact Carie Boyd's Prescription Shop for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel)by Carie Boyd Pharmaceuticals

Variants: Single-use Topical Syringe, 3mL syringe, 10/pack

Lot Numbers:

09202023@7 (Exp 03/18/2024)

09202023

NDC:

73271-1003-1

Rx only product

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 93316

Status: Resolved

Manufacturer: Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Sold By: Carie Boyd's Prescription Shop; Carie Boyd Pharmaceuticals

Manufactured In: United States

Units Affected: 190 syringes

Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall involves 3mL single-use syringes of LET Gel (Lidocaine HCL 4%, Epinephrine Bitartrate 0.18%, and Tetracaine HCL 0.5%) sold under the Carie Boyd Pharmaceuticals brand. Affected units are marked with NDC 73271-1003-1 and lot number 09202023@7 (or 09202023) with an expiration date of 03/18/2024.

If you have health concerns after using this product, contact your healthcare provider or pharmacist.

Return any unused product to the place of purchase for a refund, throw it away, or contact Carie Boyd's Prescription Shop for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 93316

Status: Resolved

Manufacturer: Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Sold By: Carie Boyd's Prescription Shop; Carie Boyd Pharmaceuticals

Manufactured In: United States

Units Affected: 190 syringes

Distributed To: Nationwide